We’re using cookies to give you the best experience possible of Essity.com. Read more about the cookies we use and how to change your settings:
At the Annual General Meeting on April 2, 2020, the Board of Directors will propose that the Meeting postpones a decision regarding the dividend for 2019 until an Extraordinary General Meeting no lat[...]
Read moreHygiene and health company Essity has today published its Annual and Sustainability Report for 2019 on www.essity.com (https://www.essity.com/investors/)
Read moreNotice is given to the Shareholders of Essity Aktiebolag (publ) (”Essity”) of the Annual General Meeting of Shareholders to be held on Thursday April 2, 2020 at 3 p.m. at Stockholm Waterfront Congres[...]
Read moreEssity has today raised EUR 300m in the bond market under its Euro Medium Term Note (EMTN) program. The reoffering yield for the bond was 0.58% with a maturity on February 3, 2030, corresponding to m[...]
Read moreJANUARY 1 – DECEMBER 31, 2019 (compared with the corresponding period a year ago)
Read moreEssity’s Annual General Meeting was held today at Stockholm Waterfront Congress Center in Stockholm, Sweden
Read moreHygiene and health company Essity is strengthening its offering in incontinence products through the acquisition of the Dutch company Novioscan. The company develops a wearable ultrasound technology [...]
Read moreAs a consequence of the situation concerning the coronavirus pandemic, Essity’s Nomination Committee has decided to withdraw its proposal that Essity’s Annual General Meeting on April 2, 2020 approve[...]
Read moreEssity’s Interim report for the first quarter of 2020 will be published on April 23 at approximately 7:00 CET. In conjunction with publication, a telephone and web presentation will be held at 9:00 C[...]
Read moreThe continued spread of the coronavirus remains difficult to assess with any certainty. Essity is carefully monitoring developments.
Read moreHygiene and health company Essity has signed an agreement to acquire 75% of the Swedish medical solutions company ABIGO Medical AB. The company as a whole is valued at SEK 900m on a debt-free basis. [...]
Read more
USA 
Russia 
Germany 
Mexico 
Netherlands 
France 
Sweden 
Italy 
Spain 
